Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 5, 2013

Biota, CEL-SCI, CPP, Genocea, Immunicum, Lilly, Sanofi, Soligenix

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Genocea begins T-directed vaccine trial . . . read more Immunicum optimistic about renal cancer vaccine results . . . read more Phase II Biota doses patients in northern hemisphere for flu trial . . . read more Soligenix launches IDR trial against oral mucositis . . . read more Phase III CEL-SCI gets approval for trial in Bosnia . . . read more CPP Opens FAP trial . . . read more Lilly depression treatment fails trial . . . read more Sanofi posts good Lyxumia results . . . read mo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters